PDS Biotechnology CorporationPDSBNASDAQ
LOADING
|||
Cash Flow Performance
Trending lower, above historical average, strong compound growth.
Left:
||||
Free cash flow yield
Latest
-59.00%
↑ 83% above average
Average (9y)
-339.52%
Historical baseline
Range
High:-6.02%
Low:-3094.69%
CAGR
+27.6%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | -59.00% | -169.8% |
| 2023 | -21.87% | -221.1% |
| 2022 | -6.81% | -13.1% |
| 2021 | -6.02% | +83.6% |
| 2020 | -36.69% | +73.8% |
| 2019 | -140.10% | +95.5% |
| 2018 | -3094.69% | -21460.4% |
| 2017 | -14.35% | -57.5% |
| 2016 | -9.11% | -38.6% |
| 2015 | -6.58% | - |